输注异体相关HLA不匹配的间充质干细胞用于治疗自体造血干细胞移植后植入不完全的情况。 - Suppr

Suppr

超能文献

Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.

作者信息

Fouillard L, Chapel A, Bories D, Bouchet S, Costa J-M, Rouard H, Hervé P, Gourmelon P, Thierry D, Lopez M, Gorin N C

出版信息

Leukemia. 2007 Mar;21(3):568-70. doi: 10.1038/sj.leu.2404550. Epub 2007 Jan 25.

DOI:10.1038/sj.leu.2404550

PMID:17252011

Abstract

摘要

相似文献

Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.输注异体相关HLA不匹配的间充质干细胞用于治疗自体造血干细胞移植后植入不完全的情况。

Leukemia. 2007 Mar;21(3):568-70. doi: 10.1038/sj.leu.2404550. Epub 2007 Jan 25.

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡，而不会消除移植物抗肿瘤效应。

Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.在进行非清髓性预处理后输注供体干细胞，以诱导对 HLA 不匹配的成人活体供肝移植的耐受性。

Transpl Immunol. 2004 Sep-Oct;13(2):139-46. doi: 10.1016/j.trim.2004.05.004.

Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.采用非清髓性预处理的未处理的HLA 2-3抗原错配（半相合）干细胞移植。

Biol Blood Marrow Transplant. 2006 Oct;12(10):1073-84. doi: 10.1016/j.bbmt.2006.06.007.

Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.非遗传母体抗原互补性HLA不匹配同胞间干细胞移植中的移植物排斥和超急性移植物抗宿主病

Eur J Haematol. 2007 Feb;78(2):157-60. doi: 10.1111/j.1600-0609.2006.00797.x.

Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.不匹配干细胞移植后供体淋巴细胞输注的安全性和有效性。

Biol Blood Marrow Transplant. 2006 Dec;12(12):1295-301. doi: 10.1016/j.bbmt.2006.07.014.

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.采用未处理的HLA不匹配/单倍体相合血液和骨髓移植治疗急性白血病。

Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65. doi: 10.1016/j.bbmt.2008.11.025.

Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia.共移植单倍体相合间充质干细胞以降低难治性重型再生障碍性贫血患者移植物失败的风险。

Acta Haematol. 2008;119(3):162-5. doi: 10.1159/000134015. Epub 2008 May 20.

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.在急性髓系白血病患者接受不匹配、非亲属造血干细胞移植后，使用低剂量抗胸腺细胞球蛋白成功预防急性移植物抗宿主病。

Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9.

引用本文的文献

The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal/stem cells in its treatment.白癜风的免疫发病机制及间充质基质/干细胞在其治疗中的潜在作用。

J Transl Med. 2025 Jul 1;23(1):707. doi: 10.1186/s12967-025-06627-8.

Advances in application of hypoxia-preconditioned mesenchymal stem cell-derived exosomes.缺氧预处理间充质干细胞来源外泌体的应用进展

Front Cell Dev Biol. 2024 Aug 21;12:1446050. doi: 10.3389/fcell.2024.1446050. eCollection 2024.

Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration.脐带间充质干细胞用于椎间盘退变的再生治疗

Front Cell Dev Biol. 2023 Aug 3;11:1215698. doi: 10.3389/fcell.2023.1215698. eCollection 2023.

Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.造血细胞移植后因移植物功能不良而使用胎盘扩展间充质样细胞（PLX-R18）：一项 I 期研究。

Bone Marrow Transplant. 2023 Nov;58(11):1189-1196. doi: 10.1038/s41409-023-02068-3. Epub 2023 Aug 8.

Umbilical cord mesenchymal stromal cells-from bench to bedside.脐带间充质基质细胞——从实验室到临床应用

Front Cell Dev Biol. 2022 Oct 12;10:1006295. doi: 10.3389/fcell.2022.1006295. eCollection 2022.

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options.胰腺癌中的细胞外基质：复杂网络的描述及有前景的治疗选择

Cancers (Basel). 2021 Sep 3;13(17):4442. doi: 10.3390/cancers13174442.

The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery.间充质基质细胞在神经母细胞瘤治疗中递送抗癌药物及促进造血恢复的潜力

J Pers Med. 2021 Feb 25;11(3):161. doi: 10.3390/jpm11030161.

Manipulated Mesenchymal Stem Cells Applications in Neurodegenerative Diseases.经调控的间充质干细胞在神经退行性疾病中的应用。

Int J Stem Cells. 2020 Mar 30;13(1):24-45. doi: 10.15283/ijsc19031.

Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18.胎盘源贴壁基质细胞疗法治疗血液系统疾病：PLX-R18 的病例研究。

Cell Transplant. 2018 Jan;27(1):140-150. doi: 10.1177/0963689717727543.

Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse.骨间充质干细胞移植促进小鼠创伤性脑损伤后的血管生成并改善神经功能。

Neuropsychiatr Dis Treat. 2017 Nov 6;13:2757-2765. doi: 10.2147/NDT.S141534. eCollection 2017.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验